Japanese drug-discovery biotech developing innovative therapeutics, including oncolytic virus treatments for cancer, using technologies pioneered at Kagoshima University
Japanese drug-discovery biotech developing innovative therapeutics, including oncolytic virus treatments for cancer, using technologies pioneered at Kagoshima University. It licenses drug candidates and conducts primarily in-house nonclinical studies and early clinical development, then seeks to out-license candidates to pharmaceutical companies after proof of concept.